Search

everythinglearnresearchcommunity

for

Search:↓

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Platelet-rich plasma therapy is effective and safe for skin regeneration and anti-aging.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

L-PRP and P-PRP reduced endometriosis in rats, but not significantly more than saline.

Platelet rich plasma may be beneficial for treating hair loss.

Mycophenolic acid may help treat hair loss by promoting hair growth and cell proliferation.

Platelet-rich plasma infusion improved pregnancy outcomes for women with thin endometrium.

Human placental extract may help hair growth by affecting certain cell signals and could be more effective with minoxidil.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Plucked hair can effectively monitor drug effects in cancer treatment.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

PRP injections significantly improve hair regrowth in alopecia areata.

PRP is useful for hair restoration.

Tofacitinib might be used to treat hair loss.

A protein called sFRP4 can partly inhibit hair growth.

Gefitinib can cause hair loss without scarring.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Ribonucleotide excision repair is crucial to prevent skin cancer.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.